Analyst Ratings For AstraZeneca plc (LON:AZN)
Today, JPMorgan Chase & Co. set its price target on AstraZeneca plc (LON:AZN) to GBX 7,100 per share.
There are 13 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on AstraZeneca plc (LON:AZN) is Buy with a consensus target price of GBX 6,297.20 per share, a potential .
Some recent analyst ratings include
- 3/29/2019-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Jefferies Financial Group with a GBX 6,400 price target
- 3/29/2019-AstraZeneca plc (LON:AZN) had its Neutral rating reiterated by Bryan, Garnier & Co
- 3/29/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital
- 3/29/2019-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Liberum Capital
- 3/18/2019-AstraZeneca plc (LON:AZN) had its Sell rating reiterated by Goldman Sachs Group
- 3/11/2019-AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays
Recent Trading Activity for AstraZeneca plc (LON:AZN)
Shares of AstraZeneca plc closed the previous trading session at 6,119.00 −377.00 5.80% with shares trading hands.